Morphosys Presents Multiple Analyses Of The MANIFEST Phase 2 Trial Investigating The Potential Of Pelabresib In The Treatment Of Myelofibrosis At EHA 2022

Press/Media

Period10 Jun 2022

Media coverage

1

Media coverage